Aiosyn and Pramana partner for real time kidney biopsy assessment
Aiosyn and Pramana are collaborating to deliver real-time analysis of kidney structures in histology whole-slide images (WSIs). Under the partnership, Netherlands-based …
Aiosyn and Pramana are collaborating to deliver real-time analysis of kidney structures in histology whole-slide images (WSIs). Under the partnership, Netherlands-based …
The Democratic Republic of Congo (DCR) has said that the freeze in US funding is impacting operations on the ground …
Researchers from Mount Sinai’s Icahn School of Medicine, US, have introduced an AI sleep analysis tool, designed to process a …
GE HealthCare has launched new editions of its three invasive cardiac software solutions. Applying to the medtech giant’s Mac-Lab, CardioLab, and …
Brazilian Health Regulatory Agency (ANVISA) has granted approval for Telix Pharmaceuticals’ Illuccix, a prostate cancer imaging agent. Illuccix claims to be …
Subtle Medical has gained the CE mark certification in Europe for its software solution SubtleHD, designed to enhance the quality …
Hyperfine is collaborating with NVIDIA to advance the AI capabilities of the Swoop Portable magnetic resonance imaging (MRI) system. The companies …
The US Food and Drug Administration (FDA) has added haemodialysis bloodlines to its medical device shortages list amid supply disruptions. The …
The new edition of our digital magazine is out now – you can read it online for free. Here are some …
A US-based team of researchers from Vanderbilt University Medical Center (VUMC) and the Rollins School of Public Health has developed …
RetinaLogik has secured Class II medical device approval from Health Canada for its visual field exam platform. Coming in the form …
Researchers at the University of Calgary (UCalgary) in Canada are set to make use of nuclear adrenal imaging, specifically a …
US medical device company Laplace Interventional has completed a Series C financing round to support the completion of an early …
The healthcare industry is second only to finance in the volume of sensitive data held. Therefore, the onus is on medical …
C2N Diagnostics has received a $10m strategic investment out of Samsung’s life science investment fund. The US company said the cash …